Thermo Fisher Scientific Extends Tender Offer for Dionex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Thermo Fisher Scientific today announced it has extended its $2.1 billion offer to purchase Dionex.

Its offer to acquire all outstanding shares of the chromatography firm at $118.50 per share is now set to expire at midnight EDT Feb. 17. All other terms of the deal remain, the company said, adding the acquisition is anticipated to be completed later this quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."